Abstract
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that affects predominantly women during their reproductive years. As expected, pregnancy is a common event in these women. A better understanding of the disease, the advances of the treatment, and creation of specialized multidisciplinary groups with experience in autoimmune diseases (involving physicians, obstetricians, pediatricians, and midwives) have led to dramatic improvement in disease management and pregnancy outcome over the last 20 years. However, maternal and fetal complications are still present. Risk factors for fetal and obstetric complications are disease activity at the conception and during pregnancy, lupus nephritis, arterial hypertension, positive antiphospholipid antibodies, and anti-Ro/SSA antibodies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Donaldson LB, De Alvarez RR (1962) Further observations on lupus erythematosus associated with pregnancy. Am J Obstet Gynecol 83:1461–1473
Ellis FA, Bereston ES (1952) Lupus erythematosus associated with pregnancy and menopause. AMA Arch Derm Syphilol 65:170–176
Khamashta MA (2006) Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol 20:685–694
Cervera R, Font J, Carmona F, Balasch J (2002) Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium. Autoimmun Rev 1:354–359
Boumpas DT, Austin HA, Vaughan EM et al (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369
Ruiz-Irastorza G, Khamashta MA (2008) Lupus and pregnancy: ten questions and some answers. Lupus 17:416–420
Clowse MEB, Magder LS, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52:514–521
Lima F, Khamashta MA, Buchanan NMM et al (1996) A study of sixty pregnancies in patients with antiphospholipid syndrome. Clin Exp Rheumatol 14:131–136
Ramsey-Goldman R, Kutzer JE, Kuller LH et al (1993) Pregnancy outcome and anti-anticardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 138:1057–1069
Germain S, Nelson-Piercy C (2006) Lupus nephritis and renal disease in pregnancy. Lupus 15:148–155
Branch DW, Khamashta MA (2003) Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol 101:1333–1344
Brucato A, Frassi M, Franceschini F et al (2001) Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44:1832–1835
Cuadrado MJ, Mendonca LLF, Khamashta MA et al (1999) Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia. Arthritis Rheum 42:S265
Bonnin M, Mercier FJ, Sitbon O et al (2005) Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 102:1133–1137
Mc Millan E, Martin WL, Waugh J et al (2002) Management of pregnancy in women with pulmonary hypertension secondary to SLE and antiphospholipid syndrome. Lupus 11:392–398
Ostensen M, Khamashta MA, Lockshin M et al (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8:209–227
Ostensen M, Lockshin M, Doria A et al (2008) Update on safety during pregnancy of biological agents and some immunosuppressive antirheumatic drugs. Rheumatology 47:28–31
Clowse MEB, Magder L, Witter F et al (2006) Hydroxycloroquine in lupus pregnancy. Arthritis Rheum 54:3640–3647
Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA (2010) Clinical efficacy of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 69:20–28
Buchanan NM, Toubi E, Khamashta MA et al (1996) Hydroxicloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 55:486–488
Costedoat-Chalumeau N, Amoura Z, Duhaut P et al (2003) Safety of hydroxycloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 48:3207–3211
Mintz G, Nitz J, Gutierrez G et al (1986) Prospective study of pregnancy in systemic lupus erythematosus: results of a multi-disciplinary approach. J Rheumatol 13:732–739
Lockshin MD, Reinitz E, Druzin ML et al (1984) Lupus pregnancy: case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 77:893–898
Urowitz MB, Gladman DD, Farewell VT et al (1993) Lupus and pregnancy studies. Arthritis Rheum 36:1392–1397
Petri M, Howard D, Repke J (1991) Frequency of lupus flare in pregnancy: the Hopkins lupus pregnancy center experience. Arthritis Rheum 34:1538–1545
Ruiz-Irastorza G, Lima F, Alves J et al (1996) Increased rate of lupus flare during pregnancy and puerperium. Br J Rheumatol 35:133–138
Wong KL, Chan FY, Lee XP (1991) Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 151:269–273
Tandon A, Ibanez D, Gladman DD et al (2004) The effect of pregnancy on lupus nephritis. Arthritis Rheum 50:3941–3946
Levy RA, Vilela VS, Cataldo MJ et al (2001) Hydroxycloroquine in lupus pregnancy: double-blind and placebo -controlled study. Lupus 10:401–404
Cortes-Hernandez J, Ordi-Ros J, Paredes F et al (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology 41:643–650
Khamashta MA, Ruiz-Irastorza G, Hughes GRV (1997) Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 23:15–30
Petri M (2007) The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin N Am 33:27–35
Hayslett JP, Lynn RI (1980) Effect of pregnancy in patients with lupus nephropathy. Kidney Int 18:207–220
Jungers P, Dougados M, Pelissler C et al (1982) Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 142:771–776
Imbasciati E, Surian M, Bottino S et al (1984) Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis. Nephron 36:46–51
Packham DK, Lam SS, Nicholls K et al (1992) Lupus nephritis and pregnancy. Q J Med 83:315–324
Julkunem H (1998) Renal lupus in pregnancy. Scand J Rheumatol 27:80–83
Huong DT, Wechsler B, Vauther-Brouzes D et al (1994) Pregnancy and its outcome in systemic lupus erythematosus. Q J Med 87:721–729
Oviasu E, Hicks J, Cameron JS (1991) The outcome of pregnancy in women with lupus nephritis. Lupus 1:19–25
Moroni G, Quaglini S, Banfi G et al (2002) Pregnancy in lupus nephritis. Am J Kidney Dis 40:713–720
Imbasciati E, Tincani A, Gregorini G et al (2009) Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 24(2):344–347
Zulman J, Tala N, Hoffman GS et al (1980) Problems associated with the management of pregnancies in patients with systemic lupus erythematosus. J Rheumatol 7:37–49
Bobrie G, Liote F, Houiller P et al (1987) Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 9:339–343
Carmona F, Font J, Moga I et al (2005) Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 53:182
Moroni G, Ponticelli C (2005) Pregnancy after lupus nephritis. Lupus 14:89–94
Day CJ, Lipkin GW, Savage COS (2009) Lupus nephritis and pregnancy in the 21 st century. Nephrol Dial Transplant 24:344–347
Smyth A, Oliveira GH, Lahr BD et al (2010) A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5:2060–2068
Milne F, Redman C, Walker J et al (2005) The preeclampsia community guideline (PRECOG): how to screen for and detect onset of preeclampsia in the community. Br Med J 330:576–580
Barton JR, Sibai BM (2008) Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 112:359–372
Mackillop LH, Germain SJ, Nelson-Piercy C, Hughes GRV (2002) Effects of lupus and antiphospholipid syndrome on pregnancy. Yearb Obstet Gynecol 10:105–119
Askie LM, Duley L, Henderson-Smart DJ, PARIS Collaborative Group et al (2007) Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data. Lancet 369:1791–1798
North RA, Ferrier C, Gamble C et al (1995) Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease. Aust N Z J Obstet Gynaecol 35:357–362
Sergio F, Maria Clara D, Gabriella F et al (2006) Prophylaxis of recurrent preeclampsia: low molecular weight heparin plus low dose aspirin versus low dose aspirin alone. Hypertens Pregnancy 25:115–127
Mecacci F, Bianchi B, Pieralli A et al (2009) Pregnancy outcome in systemic lupus erythematosus complicated by antiphospholipid antibodies. Rheumatology 48(3):246–249
Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in SLE and in non-SLE disorders. Ann Intern Med 112:682–698
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definitive antiphospholipid syndrome. J Thromb Haemost 4:295–306
Lima F, Buchanan NM, Khamashta MA et al (1995) Obstetric outcome in systemic lupus erythematosus. Semin Arhtritis Rheum 25:184–192
Opatrny L, David M, Kahn SR et al (2006) Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 33:2214–2221
Derksen RH, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028–1039
Empson M, Lassere M, Craig J et al (2005) Prevention of recurrent miscarriages for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 18(2), CD002859
Petri M, Qazi U (2006) Management of the antiphospholipid syndrome in pregnancy. Rheum Dis Clin N Am 32:591–607
Ruiz Irastorza G, Khamashta MA (2007) Antiphospholipid syndrome in pregnancy. Rheum Dis Clin N Am 33:287–297
Carmona F, Font J, Azulay M et al (2001) Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate análisis. Am J Reprod Immunol 46:274–279
Ruiz Irastorza G, Khamashta MA, Hughes GRV (2002) Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rev 1:298–304
Ruiz Irastorza G, Khamashta MA (2005) Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Am N Y Acad Sci 1051:606–612
Ruiz Irastorza G, Khamashta MA, Nelson-Piercy C et al (2001) Lupus pregnancy: is heparin a risk factor for osteoporosis? Lupus 10:597–600
Gordon P, Khamashta MA, Rosenthal E et al (2004) Anti-52 kDa Ro, anti-60 kDa Ro and anti La antibody profiles in neonatal lupus. J Rheumatol 31:2480–2487
Buyon JP, Hiebert R, Copel J et al (1998) Autoimmune associated congenital heart block: demographics, mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31:1658–1666
Saleeb S, Copel J, Friedman D et al (1999) Comparison of treatment with fluorinated glucocorticoids to the national history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 42:2335–2345
Friedman D, Kim MY, Copel JA et al (2008) Utility of cardiac monitoring in fetuses at risk for congenital heart block (PRIDE) prospective study. Circulation 117:485–493
Pisoni CN, Brucato A, Ruffatti A et al (2010) Intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum 62:1147–1152
Friedman DM, Llanos C, Izmirly PM et al (2010) Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 62:1138–1146
Izmirly PM, Kim MY, Llanos C, Le PU et al (2010) Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxycloroquine. Ann Rheum Dis 69:1827–1830
Ostensen M, Forger F (2013) How safe are anti-rheumatic drugs during pregnancy? Curr Opin Pharmacol 13:1–6
Fischer-Betz R, Specker C, Brinks R et al (2013) Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology (Oxford) 52(6):1070–1076
Auyeung-Kim DJ, Devalaraja MN, Migone TS et al (2009) Development and peri postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B lymphocyte stimulator. Reprod Toxicol 28:443–455
GlaxoSmithKline (2013) Use of intravenous (IV) benlysta in pregnant patients with systemic lupus erythematosus (SLE)
Peart E, Clowse MEB (2014) Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature. Curr Opin Rheumatol 26:118–123
Webster P, Wardle A, Bramham K et al (2014) Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus 0:1–5
Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al (2012) Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 126(1):76–82
Barsalou J, Jaeggi E, Tian SY et al (2014) A149: does prenatal exposure to antimalarial decrease the risk of neonatal lupus: a Bayesian perspective. Arthritis Rheumatol 66(Suppl 11):S193
Ateka-Barrutia O, Khamashta MA (2013) The challenge of pregnancy for patients with SLE. Lupus 22:1295–1308
Cnossen JS, Morris RK, ter Riet G et al (2008) Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable metaanalysis. CMAJ 178:701–711
Madazli R, Yuksel MA, Oncul M et al (2014) Obstetric outcomes and prognostic factors of lupus pregnancies. Arch Gynecol Obstet 289(1):49–53
Morris RK, Malin G, Robson SC et al (2011) Fetal umbilical artery Doppler to predict compromise of fetal/neonatal wellbeing in a high risk population: systematic review and bivariate meta-analysis. Ultrasound Obstet Gynecol 37:135–142
Saavedra MA, Cruz-Reyes C, Vera Lastra O et al (2012) Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol 31:813–819
Brito-Zeron P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA. Nat Rev Rheumatol 2015;11(5):301–12.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Alba, P., Khamashta, M. (2016). Systemic Lupus Erythematosus and Pregnancy. In: Roccatello, D., Emmi, L. (eds) Connective Tissue Disease. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-24535-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-24535-5_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24533-1
Online ISBN: 978-3-319-24535-5
eBook Packages: MedicineMedicine (R0)